Skip to content
OpenImmunosuppressive agentscs

LP s obsahem bimekizumabu 2026[E15]

Olomouc - Nová Ulice, CzechiaFakultní nemocnice Olomouc[E2]

In plain English

What they want
Předmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků s obsahem účinné látky bimekizumabu, splňující požadavky SÚKL
Who can bid
No restrictions are stated in the notice data. The tender documents may set more.
Deadline
Buyer's deadline: 27 Nov 2026, 10:00 UTC+1. UTC: 27 Nov 2026, 09:00 UTC.
Published 25 Oct 2026.
Value
CZK 28,894,769
Buyer
Fakultní nemocnice OlomoucSee what else this buyer buys and when.
Tender documents

We read the official TED notice. The full tender documents are on the buyer's own portal, linked from the notice, and we do not fetch them.

Tender documents, read for you

We read the official TED notice. The full tender documents are on the buyer's own portal, linked from the notice, and we do not fetch them.

Get the key points of the tender pack, with page references

A summary of what the documents require, a bid or no-bid checklist against your company profile, and answers to your questions with the page they come from.

Your tender documents

Download the tender pack from the buyer's portal (the invitation to tender, specification, selection questionnaire, scoring and draft contract) and add it here. We read every page and check it against your company for the bid assessment.

Sign in to upload documents.

Deadline[E6]
27 Nov 2026, 10:00 UTC+1
Value[E16]
CZK 28,894,769
Published[E14]
25 Oct 2026
Procedure[E13]
open
Last checked
14 hours ago

About the requirement

From the notice

Předmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků s obsahem účinné látky bimekizumabu, splňující požadavky SÚKL[E7]

Eligibility and requirements

  • ConditionPlace of performance: NUTS CZ071.[E8]
  • ConditionThe buyer marks the procurement as suitable for small and medium-sized businesses.[E9]
  • ConditionThe procurement is covered by the WTO Government Procurement Agreement.[E10]
  • DetailAward criteria types: price.[E1]
  • DetailThe contract duration is 36 MONTH.[E4]
  • The notice data states no restriction on who may bid. Exclusion grounds and selection criteria in the tender documents still apply.

Risks and unknowns

  • RiskThe official language is CES. Documents and bids may need to be in that language.[E12]
  • UnknownWe read the published notice, not the full tender documents.

Updates

  1. First seen · 28 Oct 2026, 09:16 UTC

    The source published a call for competition with a future deadline.

    Source document 737291-2026

Evidence

16 facts

Every fact on this page comes from the published notice. Each entry shows the document and the field it was read from.

  1. E1

    Award criteria types: price.

    Document 737291-2026, field /award-criterion-type-lot, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  2. E2

    The buyer is Fakultní nemocnice Olomouc.

    Document 737291-2026, field /buyer-name/ces, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  3. E3

    The notice is classified under CPV 33652300.

    Document 737291-2026, field /classification-cpv/0, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  4. E4

    The contract duration is 36 MONTH.

    Document 737291-2026, field /duration-period-value-lot/0, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  5. E5

    The buyer is in CZE.

    Document 737291-2026, field /buyer-country/0, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  6. E6

    Tenders must be received by 27 Nov 2026, 10:00 UTC+01:00.

    “2026-11-27+01:00 10:00:00+01:00”

    Document 737291-2026, field /deadline-receipt-tender-date-lot/0, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  7. E7

    The buyer describes the requirement (in ces).

    “Předmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků s obsahem účinné látky bimekizumabu, splňující požadavky SÚKL”

    Document 737291-2026, field /description-proc/ces, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  8. E8

    Place of performance: NUTS CZ071.

    Document 737291-2026, field /place-of-performance, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  9. E9

    The buyer marks the procurement as suitable for small and medium-sized businesses.

    “true”

    Document 737291-2026, field /sme-lot, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  10. E10

    The procurement is covered by the WTO Government Procurement Agreement.

    “true”

    Document 737291-2026, field /gpa-lot, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  11. E11

    This is a call for competition. Suppliers can respond. TED notice type: cn-standard.

    Document 737291-2026, field /notice-type, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  12. E12

    The procedure title in ces is "LP s obsahem bimekizumabu 2026".

    Document 737291-2026, field /title-proc/ces, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  13. E13

    The procedure type is open.

    Document 737291-2026, field /procedure-type, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  14. E14

    TED published the notice on 26 Oct 2026.

    “2026-10-26+01:00”

    Document 737291-2026, field /publication-date, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  15. E15

    The notice is titled "Czechia – Immunosuppressive agents – LP s obsahem bimekizumabu 2026".

    Document 737291-2026, field /notice-title/eng, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

  16. E16

    The estimated value is CZK 28,894,769.

    “28894769 CZK”

    Document 737291-2026, field /estimated-value-proc, read 28 Oct 2026, 09:16 UTC · source (opens in a new tab)

Source: Tenders Electronic Daily (TED), © European Union. Reuse authorised under Commission Decision 2011/833/EU. Data licence: EU reuse of TED data (Commission Decision 2011/833/EU) (opens in a new tab). Personal contact details in notices are not stored or shown.